Page 25 - Infi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Infi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Infi Today - Breaking & Trending Today

Infinity Pharmaceuticals (NASDAQ:INFI) Issues Earnings Results, Beats Expectations By $0.01 EPS

Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) announced its quarterly earnings results on Tuesday. The biotechnology company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.01, MarketWatch Earnings reports. Infinity Pharmaceuticals had a negative return on equity of 172.12% and a negative net margin of 2,398.81%. During the same period last […] ....

United Kingdom , United States , Stevenh Holtzman , Piper Sandler , Earnings History For Infinity Pharmaceuticals , Zacks Investment Research , America Corp , Invesco Ltd , Citigroup Inc , Infinity Pharmaceuticals Inc , Infinity Pharmaceuticals Company Profile Get Rating , Infinity Pharmaceuticals , Get Rating , Marketwatch Earnings , Investment Research , Pharmaceuticals Company Profile , Nasdaq Infi ,

$410,000.00 in Sales Expected for Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) This Quarter

Wall Street analysts expect Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating) to report $410,000.00 in sales for the current quarter, according to Zacks. Five analysts have issued estimates for Infinity Pharmaceuticals’ earnings. The highest sales estimate is $550,000.00 and the lowest is $200,000.00. Infinity Pharmaceuticals reported sales of $440,000.00 in the same quarter last year, […] ....

United States , United Kingdom , Stevenh Holtzman , Polar Capital Holdings Plc , Board Of Administration Florida Retirement System , Zacks Investment Research , Franklin Resources Inc , Advisors Inc , Sigma Securities , Infinity Pharmaceuticals Inc , Infinity Pharmaceuticals Company Profile Get Rating , Infinity Pharmaceuticals , Wall Street , Get Rating , Infinity Pharmaceutical , Investment Research , Capital Holdings Plc , Florida Retirement System , Franklin Resources , Pharmaceuticals Company Profile , Nasdaq Infi ,

Brokerages Set Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) PT at $8.40

Shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating) have earned a consensus rating of “Buy” from the seven ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the […] ....

United Kingdom , Stevenh Holtzman , Tradewinds Capital Management , Zacks Investment Research , Parametric Portfolio Associates , Advisors Inc , Sigma Securities , Analyst Recommendations For Infinity Pharmaceuticals , Infinity Pharmaceuticals Get Rating , Citigroup Inc , Infinity Pharmaceuticals Inc , Infinity Pharmaceuticals , Get Rating , Marketbeat Ratings , Portfolio Associates , Capital Management , Two Sigma Securities , Nasdaq Infi ,

Adam L. Gray Purchases 547,000 Shares of NFI Group Inc. (TSE:NFI) Stock

NFI Group Inc. (TSE:NFI – Get Rating) Director Adam L. Gray bought 547,000 shares of the stock in a transaction dated Friday, March 18th. The shares were acquired at an average price of C$16.01 per share, for a total transaction of C$8,757,470.00. Following the completion of the transaction, the director now owns 8,537,387 shares of […] ....

United States , United Kingdom , Asia Pacific , Adaml Gray , Group Company Profile Get Rating , Nfi Group Inc , Alexander Dennis , Group Inc , National Bankshares , Get Rating , Director Adam , Company Profile , North America , Manufacturing Operations , New Flyer , Alexander Dennis Limited , Nfi Group , Tse Nfi , Consumer Cyclical , Insider Trading , Nsider Trades ,

Adam L. Gray Buys 100,000 Shares of NFI Group Inc. (TSE:NFI) Stock

NFI Group Inc. (TSE:NFI – Get Rating) Director Adam L. Gray purchased 100,000 shares of NFI Group stock in a transaction that occurred on Wednesday, March 23rd. The shares were bought at an average cost of C$16.47 per share, for a total transaction of C$1,647,000.00. Following the completion of the transaction, the director now directly […] ....

United States , United Kingdom , Asia Pacific , Adaml Gray , Nfi Group Inc , Group Get Rating , Alexander Dennis , Group Inc , Get Rating , Director Adam , Cap Markets , North America , Manufacturing Operations , New Flyer , Alexander Dennis Limited , Nfi Group , Tse Nfi , Consumer Cyclical , Insider Trading , Nsider Trades ,